Hypertension Circulatory System
Conditions
Interventions
Participants will be identified through demographic surveillance systems and approached to participate. Those who consent will be entered into the study. Participants will have their blood pressure me
Sponsors
London School of Hygiene & Tropical Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Registered in population registers of the KWHDSS (The Gambia) or KHDSS (Kenya) 2. Aged =30 years at the time of enrolment in the study 3. Able to provide written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Pregnant women (self-reported)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at baseline: 1. Blood pressure measured by 24-hr ABPM, HBPM, and u/aABPM. 2. Left ventricular hypertrophy measured by transthoracic echocardiogram, 12-lead electrocardiogram and smartphone based 6-lead ECG 3. Left ventricular systolic dysfunction assessed transthoracic echocardiogram, and smartphone based 6-lead ECG 4. Hypertensive retinopathy measured using clinical grade retinal camera and smartphone-based portable retinal cameras 5. Renal dysfunction measured using clinical laboratories and point-of-care clinical chemistry devices 6. Arterial stiffness measured using blood-pressure cuff assessment of pressure wave velocity | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cardiovascular risk factors assessed using questionnaire at baseline 2. Participant demographics assessed using questionnaire at baseline | — |
Countries
Gambia, Kenya
Contacts
Public ContactAlexander Perkins
Outcome results
None listed